Global Retirement Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
Other funds holding ITCI
WA
ACA
BG
DTC
Global Retirement Partners's ITCI Position: Q4 2024 in Review
Global Retirement Partners increased its Intra-Cellular Therapies Inc. (ITCI) stake by 30% in Q4 2024, buying an estimated $3.29K and bringing the position to 174 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.
Global Retirement Partners first reported a position in ITCI in Q3 2019 and has held it in 21 quarters since. The position peaked at $97.5K in Q2 2023. 387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.
- Global Retirement Partners held 174 shares of Intra-Cellular Therapies Inc. worth $14.5K as of Q4 2024.
- Global Retirement Partners bought 40 Intra-Cellular Therapies Inc. shares in Q4 2024, an estimated $3.29K.
- Intra-Cellular Therapies Inc. made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #2250 holding.
- Global Retirement Partners first reported a position in Intra-Cellular Therapies Inc. in Q3 2019 and has held it in 21 quarters since.
- Global Retirement Partners's Intra-Cellular Therapies Inc. position peaked at $97.5K in Q2 2023.
- 387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.
Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.